This
report on antibacterial drugs market studies the current as well as
future prospects of the market globally. Antibacterial drugs are
agents that are utilized to check the growth of bacterial strains in
living organisms, which are responsible for several mild to severe
infections. These drugs exhibit bactericidal activity that targets
different physiological processes of harmful bacteria, such as,
nucleic acid synthesis, cell wall synthesis, protein synthesis, and
permeability of cell membrane, thus help treat various infections.
This report comprises an elaborate executive summary, which includes
a market snapshot that provides overall information of various
segments and sub-segments that are contained in the report. It also
provides an overall information and data analysis of the global
antibacterial drugs market with respect to market segments based on
drug class, and geographic regions.
Browse
Global Antibacterial Drugs Market Report with Full TOC at
http://www.transparencymarketresearch.com/antibacterial-drugs-market.html
The
market for antibacterial drugs is segmented based on major classes of
drugs, namely, aminoglycosides, β-lactams, tetracyclines,
sulfonamides, quinolones/fluoroquinolones, macrolides and phenicols.
The market for these classes has been extensively analyzed based on
the leading drug launch, expiry, efficacy, sales revenue and
geographic presence. The market size and forecast in terms of USD
million for each of these classes has been provided for the period
2011 to 2019. β-lactams being the largest drug class, has been
further classified into three major sub-segments, namely,
penicillins, carbapenems, and cephalosporins. Elaborate qualitative
information for these subclasses has been provided in separate
sub-sections of this report. The report on antibacterial drugs market
also provides value percent of compounded annual growth rate (CAGR)
for each market segment for the forecast period 2013 to 2019,
considering 2012 as the base year.
Geographically,
the antibacterial drugs market has been categorized into four regions
namely, North America, Europe, Asia-Pacific, and Rest of the World
(ROW). The market sizes and forecasts for each of these regions have
been provided for the period 2011 to 2019 along with CAGR (Value %)
for the forecast period 2013 to 2019. The research study also
incorporates the competitive scenario in these regions. A detailed
qualitative analysis of the factors responsible for driving and
restraining the growth of global antibacterial drugs market and
future opportunities has been provided in the market overview
section. This section of the report also deals with market
attractiveness analysis and Porter’s five forces analysis for the
antibacterial drugs market.
Request
for customization of this report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1567
The
report also includes pipeline analysis for the antibacterial drugs
market that comprises sales forecast for various drugs currently
under phase III clinical trials and expected to be launched within
the forecast period. Some of the major drugs that have been profiled
in this section include Tedizolid, Dalbavancin, Oritavancin,
Delafloxacin, Ceftolozane/Tazobactam, CAZ-AVI, Surotomycin,
Solithromycin, Eravacycline, MK-3415A and Delamanid. The forecast
market size in terms of USD million for each of these drugs has been
provided for the period 2013 to 2019, considering their launch during
the forecast period. This chapter also provides % compounded annual
growth rate (CAGR) for each drug for the forecast period 2013 to
2019. This report also includes a chapter on competitive landscape
that includes market share analysis of the leading players in the
antibacterial drugs market, in terms of their market share (Value %)
in the year 2012. A list of recommendations has also been provided
for new entrants as well as existing market players to help them
establish a strong presence in the market and increase their market
share.
Browse
all Press Releases:
http://www.transparencymarketresearch.com/press-releases.htm
The
report also profiles major players of the antibacterial drugs market
based on various attributes such as company overview, financial
overview, business strategies, product portfolio and recent
developments. Some of the major players profiled in this report
include AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli
Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc,
Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer,
Inc., and Sanofi.
Browse
all Article :
http://www.transparencymarketresearch.com/articles.htm
The
global antibacterial drugs market is segmented as follows:
Antibacterial
Drugs Market, by Class
Aminoglycosides
β-Lactams
Tetracyclines
Sulfonamides
Quinolones/Fluoroquinolones
Macrolides
Phenicols
Antibacterial
Drugs Market, by Geography
North
America
Europe
Asia-Pacific
Rest
of the World (RoW)
Browse
all Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Sheela
AK
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Blog:
http://www.tmrblog.com/
No comments:
Post a Comment